Fernández JC, Calvo LN, Vázquez EG, García MJG, Pérez MTA, Silva IM, Seara JF. Risk factors associated with the development of ischemic colitis. World J Gastroenterol 2010; 16(36): 4564-4569 [PMID: 20857527 DOI: 10.3748/wjg.v16.i36.4564]
Corresponding Author of This Article
Joaquín Cubiella Fernández, MD, Department of Gastroenterology, Complexo Hospitalario de Ourense, 32005 Ourense, Spain. joaquin.cubiella.fernandez@sergas.es
Article-Type of This Article
Brief Article
Open-Access Policy of This Article
This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Brief Article
Copyrightcopy;2010 Baishideng Publishing Group Co.
World J Gastroenterol. Sep 28, 2010; 16(36): 4564-4569 Published online Sep 28, 2010. doi: 10.3748/wjg.v16.i36.4564
Table 1 Diagnosis of ischemic colitis
n (%)
Endoscopic location
Pancolitis
3 (1.9)
Right colon
10 (6.5)
Transverse colon
34 (21)
Splenic angle
36 (23.2)
Descending colon
69 (44.5)
Sigmoid colon
106 (68.4)
Rectum
38 (24.5)
Endoscopic findings
Hyperemia
98 (65.3)
Petechiae
37 (24.7)
Intramucosal bleeding
30 (20)
Fibrin
43 (26.5)
Ulcers
84 (56)
Active bleeding
9 (6)
Necrosis
12 (8)
Estenosis
12 (8)
Histologic findings
Crypt loss
17 (14.7)
Epithelium loss
13 (8)
Edema
68 (58.6)
Inflamatory infiltrate
87 (75)
Capillar thrombosis
17 (14.7)
Necrosis
40 (34.5)
Hemorrhage
1 (2.5)
Table 2 Clinical characteristics present in cases and controls
Case (%)
Control (%)
P value
OR
95% CI
Arterial hypertension
56.5
46.6
0.034
1.543
1.035-2.301
Dyslipidemia
19.8
12.1
0.025
1.793
1.075-2.992
Diabetes mellitus
26.7
12.7
< 0.001
2.427
1.506-3.911
Smoking habit
10.5
9.9
0.825
1.075
0.564-2.049
Chronic renal failure
4.3
4.6
0.877
0.93
0.372-2.33
Valve heart disease
7.4
6.8
0.806
1.094
0.535-2.234
Ischemic heart disease
18
14.9
0.381
1.254
0.756-2.08
Hypertensive heart disease
15.5
13.4
0.516
1.195
0.698-2.044
Atrial fibrillation
14.3
14
0.923
1.028
0.585-1.808
Heart failure
10.5
5
0.026
2.253
1.103-4.604
Peripheral arteriopathy
8.1
2.2
0.004
4.658
1.643-13.21
Abdominal aorta surgery
1.2
0
0.096
Cerebrovascular disease
12.4
9.6
0.339
1.348
0.731-2.483
COPD
18
18.6
0.864
0.956
0.576-1.587
Table 3 Medications taken by cases and controls
Case (%)
Control (%)
P value
OR
95% CI
Antihypertensives
51.5
41
0.023
1.595
1.067-2.383
Beta-blockers
5.6
5.6
1
1
0.443-2.26
Ca2+ channel antagonists
22.3
14.6
0.027
1.771
1.065-2.946
ACE inhibitors
27.3
18.3
0.018
1.776
1.102-2.861
Nitrates
10.5
9.3
0.67
1.143
0.617-2.117
ARB
1.2
4
0.109
0.358
0.102-1.259
NSAIDs
10.5
9.9
0.823
1.077
0.561-2.07
Digoxin
3.1
7.4
0.060
0.383
0.141-1.042
Antidepressants
3.7
6.2
0.222
0.540
0.201-1.453
Diuretics
26.1
26.1
1
1
0.656-1.525
ASA
31.6
18
< 0.001
2.153
1.371-3.382
Acenocumarol
5.6
5.6
1
1
0.443-2.26
Table 4 Multivariant conditional logistic regression model
Variables
P value
Coefficient
OR
95% CI
Diabetes mellitus
0.04600
0.5671
1.7632
1.0101-3.0776
Dyslipidemia
0.00437
0.7550
2.1277
1.2658-3.5762
Heart failure
0.01064
1.1539
3.1705
1.3079-7.6853
Peripheral arteriopathy
0.01461
1.4109
4.0997
1.3211-12.7219
Digoxin
0.02651
-1.3173
0.2679
0.0836-0.8576
Acetylsalicylic acid
0.01219
0.6808
1.9755
1.1600-3.3640
Heart disease
0.14541
-0.4224
0.6554
0.3711-1.1575
Citation: Fernández JC, Calvo LN, Vázquez EG, García MJG, Pérez MTA, Silva IM, Seara JF. Risk factors associated with the development of ischemic colitis. World J Gastroenterol 2010; 16(36): 4564-4569